Navigation Links
Renhuang Pharmaceuticals, Inc. Announces Solid Fourth Quarter and Fiscal Year 2007 Results
Date:5/29/2008

HARBIN, China, May 29 /Xinhua-PRNewswire-FirstCall/ -- Renhuang Pharmaceuticals, Inc. (Pink Sheets: RHGP) ("Renhuang" or "the Company"), a leading pharmaceutical company in the People's Republic of China ("PRC"), today reported solid financial results for the fourth quarter and fiscal year ended October 31, 2007.

Fourth Quarter Fiscal 2007 Highlights

-- Total revenues increased to $7.1 million, up 5% from the fourth

quarter of 2006

-- Gross profit reached $3.6 million, up 19% from the fourth quarter of

2006

-- Gross margin was 51%, up from 45% in the fourth quarter of 2006

-- Operating income totaled $1.1 million

-- Net income was $1.1 million, or $0.03 per diluted share

Full Year 2007 Highlights

-- Total revenues in 2007 were $28.0 million

-- Gross profit in 2007 was $14.3 million

-- Gross margin was 51%

-- Operating income was $9.6 million

-- Net income increased to $9.6 million, or $0.27 per fully diluted share

"This was a very key year for Renhuang Pharmaceuticals. We performed well on promotions and advertisements and enhanced our production processes. We also focused on our best selling product, Acanthopanax, and continued to work with scientific institutions to enhance our research and development capabilities," said Mr. Shaoming Li, Chairman and CEO of Renhuang. "We will continue to maintain this strategy in the year ahead and plan to explore new markets and increase sales."

Fourth Quarter 2007 Results

Renhuang's total revenues in the fourth quarter were $7.1 million, a slight increase of 5% over the fourth quarter of 2006. This was attributed to sales of its Acanthopanax products, which accounted for about 51% of the total revenues

Gross profit in the fourth quarter of 2007 was $3.6 million, an increase of 19% over the fourth quarter of 2006. Gross margin for the quarter increased to 51% from 45% in the fourth quar
'/>"/>

SOURCE Renhuang Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
2. AMAG Pharmaceuticals, Inc. and 3SBio, Inc. Announce Strategic Partnership to Develop and Commercialize Ferumoxytol in China
3. Jazz Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
4. Medimetriks Pharmaceuticals, Inc. Begins Operations
5. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
6. Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
7. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2008 Financial Results on Monday, May 12, at 8:30 A.M. EDT
8. Jazz Pharmaceuticals, Inc. to Announce First Quarter Results on May 13, 2008
9. Aida Pharmaceuticals, Inc. Announces Update on Progress of Rh-Apo2L Testing
10. Aida Pharmaceuticals, Inc. Announces Completion of Research Institute Acquisition
11. GlaxoSmithKline to Acquire Sirtris Pharmaceuticals, a World Leader in Sirtuin Research and Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... (PRWEB) December 18, 2014 iLab Solutions, ... the appointment of Siri Bryant as the new Director ... Director of Core Implementations. These two new leadership positions ... customer service by ensuring that iLab continues to meet ... the last four years, iLab has been deployed at ...
(Date:12/19/2014)... The empty capsules market is experiencing growth ... technological innovations in the empty capsules market. The ... growth of the empty capsules market. , Get ... of Report , The report will enrich both ... to gauge the pulse of the market which ...
(Date:12/19/2014)... -- Decision Resources Group finds that the Asia ... through 2023 as the aging population, increasing adoption of ... all spur procedure volumes. Growth will be particularly rapid ... and India , where rising ... a larger proportion of the population. Other ...
(Date:12/19/2014)... --  ISN has released its third annual U.S. ... publication series. With data aggregated from over eight billion ... its online contractor management platform, ISNetworld, this three-part series ... statistics. The Contractor Performance ... available in two industry specific volumes: Oil & ...
Breaking Biology Technology:iLab Solutions Announces Two New Leadership Positions to Meet the Needs of Its Growing Customer Base 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 2Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 3Empty Capsules Market Hit to Reach $1,820 Million by 2019 - New Research Report by MarketsandMarkets 4Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 2Asia Pacific Dental Biomaterial Market Will Grow Strongly Through 2023 3ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 2ISN Releases Third Edition of US Contractor Health & Safety Performance Indicators Publication Series 3
... America,s,pharmaceutical and biotechnology research companies invested a ... development of new life-changing,medicines and vaccines -- an ... analyses by the Pharmaceutical Research and Manufacturers of,America ... the report coincides,with PhRMA,s 50th anniversary, which it ...
... March 24 GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), ... is very pleased to announce the addition of Dr. ... Current President/CEO,and company co-founder Don Hildebrand remains as Chairman ... be heavily involved in company,development, growth and expansion plans ...
... An information technology,revolution is improving cancer ... according to Supportive Oncology Services, Inc. (SOS), ... PROs are self-,assessments that measure any aspect ... the patient without any interpretation by the ...
Cached Biology Technology:R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007 3GeoVax Further Strengthens Management Team 2GeoVax Further Strengthens Management Team 3GeoVax Further Strengthens Management Team 4GeoVax Further Strengthens Management Team 5Patient-Reported Outcomes (PROs) Improve Cancer Treatment -- Experts Agree 2Patient-Reported Outcomes (PROs) Improve Cancer Treatment -- Experts Agree 3
(Date:12/11/2014)... 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ... 2015-2019"  report to their offering. ... advances in technology. With continuous advances in technology, ... the latest standard that meets the needs and ...
(Date:12/11/2014)... N.C. , Dec. 10, 2014  That blood pressure ... quite a while. Hypertension – the medical term for high ... the early 1800s, and the inflatable cuff that,s used in ... doesn,t, however, mean there,s nothing new about hypertension, its triggers ... long-held beliefs about the condition and the best ways to ...
(Date:12/10/2014)... Dec. 8, 2014 You,ve been here before: you ... can,t remember your password, site key or the answer to ... first grade teacher? Today, Hoyos Labs ... app that will finally put an end to the frustration ... TM . 1U leverages a user,s smartphone to acquire ...
Breaking Biology News(10 mins):Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... researchers at The Scripps Research Institute has developed a ... cells. The Scripps Research scientists initiated the ... journal Nature Methods because the availability of genetically ... development could have important medical consequences. Research has shown ...
... has found that chlorophyll and its derivative chlorophyllin are effective ... produced by a fungus that is a contaminant of grains ... liver cancer and can work in concert with other ... carefully regulated in the United States, but are often found ...
... is increased evidence that the Arctic could face seasonally ice-free ... documented evidence that the Arctic Ocean and Nordic Seas were ... warm period (3.3 to 3 million years ago). This period ... the end of this century, and is used as an ...
Cached Biology News:Scripps research team develops technique to determine ethnic origin of stem cell lines 2Scripps research team develops technique to determine ethnic origin of stem cell lines 3Chlorophylls effective against aflatoxin 2Chlorophylls effective against aflatoxin 3Arctic could face warmer and ice-free conditions 2
Antibodies were affinity purified using epitopes specific to Alpha4 immobilized on solid support....
in vitro Translation, Accessory Products...
Mouse Aminopeptidase P2/XPNPEP2 Affinity Purified PAb Protein Family: Aminopeptidases, Metalloproteases...
Request Info...
Biology Products: